Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hematopoietic Stem Cell Transplantation | 17 | 2021 | 2426 | 2.33 | Why? |
| Respiratory Syncytial Virus Infections | 7 | 2019 | 1234 | 1.79 | Why? |
| Cytomegalovirus Infections | 5 | 2020 | 667 | 1.29 | Why? |
| Hematologic Neoplasms | 4 | 2018 | 2105 | 0.91 | Why? |
| Quinazolines | 3 | 2020 | 126 | 0.88 | Why? |
| Immune Reconstitution | 1 | 2021 | 48 | 0.87 | Why? |
| Acetates | 3 | 2020 | 123 | 0.86 | Why? |
| Respiratory Tract Infections | 6 | 2018 | 6817 | 0.72 | Why? |
| Respiratory Syncytial Viruses | 2 | 2019 | 612 | 0.69 | Why? |
| Ribavirin | 3 | 2019 | 1182 | 0.66 | Why? |
| Immunocompromised Host | 6 | 2019 | 5150 | 0.65 | Why? |
| Paramyxoviridae Infections | 2 | 2017 | 364 | 0.65 | Why? |
| Leukopenia | 1 | 2018 | 280 | 0.64 | Why? |
| Cancer Care Facilities | 2 | 2018 | 1190 | 0.61 | Why? |
| Chemoprevention | 1 | 2019 | 585 | 0.56 | Why? |
| Transplant Recipients | 4 | 2021 | 4982 | 0.44 | Why? |
| Serratia Infections | 1 | 2009 | 12 | 0.41 | Why? |
| Neoplasms | 7 | 2020 | 17251 | 0.41 | Why? |
| Serratia marcescens | 1 | 2009 | 38 | 0.41 | Why? |
| Antiviral Agents | 11 | 2020 | 41703 | 0.40 | Why? |
| Syringes | 1 | 2009 | 70 | 0.39 | Why? |
| Transplantation, Homologous | 4 | 2021 | 757 | 0.39 | Why? |
| Disinfection | 3 | 2020 | 2912 | 0.37 | Why? |
| Cost of Illness | 1 | 2019 | 1903 | 0.36 | Why? |
| Palivizumab | 2 | 2018 | 32 | 0.35 | Why? |
| Operating Rooms | 1 | 2017 | 1841 | 0.31 | Why? |
| Catheter-Related Infections | 2 | 2019 | 381 | 0.28 | Why? |
| Viral Fusion Proteins | 2 | 2019 | 399 | 0.28 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.27 | Why? |
| Xenon | 2 | 2020 | 27 | 0.23 | Why? |
| Hospitals, Teaching | 1 | 2009 | 1609 | 0.22 | Why? |
| Equipment Contamination | 1 | 2009 | 1308 | 0.21 | Why? |
| Cross Infection | 4 | 2019 | 8675 | 0.20 | Why? |
| Ultraviolet Rays | 2 | 2020 | 1272 | 0.19 | Why? |
| Rubulavirus | 1 | 2018 | 5 | 0.19 | Why? |
| Cytomegalovirus | 3 | 2020 | 600 | 0.19 | Why? |
| Transplantation, Haploidentical | 1 | 2017 | 53 | 0.18 | Why? |
| Febrile Neutropenia | 1 | 2020 | 179 | 0.17 | Why? |
| Acids, Carbocyclic | 1 | 2017 | 27 | 0.17 | Why? |
| Acyclovir | 1 | 2018 | 154 | 0.17 | Why? |
| Bacterial Load | 1 | 2017 | 179 | 0.17 | Why? |
| Cyclopentanes | 1 | 2017 | 55 | 0.17 | Why? |
| Zanamivir | 1 | 2017 | 63 | 0.17 | Why? |
| Bone Marrow Transplantation | 1 | 2020 | 343 | 0.17 | Why? |
| Food Safety | 1 | 2018 | 145 | 0.16 | Why? |
| Virus Activation | 2 | 2018 | 480 | 0.16 | Why? |
| Measles-Mumps-Rubella Vaccine | 1 | 2019 | 282 | 0.15 | Why? |
| Amantadine | 1 | 2017 | 79 | 0.15 | Why? |
| Influenza, Human | 2 | 2017 | 10779 | 0.15 | Why? |
| Neutropenia | 1 | 2018 | 388 | 0.14 | Why? |
| Herpes Simplex | 1 | 2018 | 272 | 0.14 | Why? |
| Metapneumovirus | 1 | 2017 | 465 | 0.13 | Why? |
| Serum Albumin | 1 | 2017 | 571 | 0.13 | Why? |
| Urinary Tract Infections | 1 | 2019 | 534 | 0.13 | Why? |
| Young Adult | 9 | 2021 | 93724 | 0.12 | Why? |
| Oseltamivir | 1 | 2017 | 583 | 0.12 | Why? |
| Guanidines | 1 | 2017 | 499 | 0.12 | Why? |
| Retrospective Studies | 9 | 2019 | 105322 | 0.12 | Why? |
| Hypoxia | 2 | 2017 | 3626 | 0.12 | Why? |
| Humans | 31 | 2021 | 930598 | 0.12 | Why? |
| Measles | 1 | 2019 | 608 | 0.11 | Why? |
| Picornaviridae Infections | 1 | 2017 | 544 | 0.11 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2018 | 846 | 0.11 | Why? |
| Bronchoscopy | 1 | 2018 | 991 | 0.10 | Why? |
| Infection Control | 2 | 2020 | 23131 | 0.10 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.10 | Why? |
| Antimicrobial Stewardship | 1 | 2018 | 931 | 0.10 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 2309 | 0.10 | Why? |
| Adult | 12 | 2021 | 244371 | 0.10 | Why? |
| Mexico | 1 | 2017 | 2787 | 0.09 | Why? |
| Patient Care | 1 | 2020 | 1664 | 0.09 | Why? |
| Hand Disinfection | 1 | 2018 | 1671 | 0.09 | Why? |
| Aged | 10 | 2021 | 215776 | 0.09 | Why? |
| Antifungal Agents | 1 | 2018 | 1828 | 0.09 | Why? |
| Survival Rate | 2 | 2021 | 9206 | 0.08 | Why? |
| United States | 4 | 2019 | 46150 | 0.08 | Why? |
| Quality Improvement | 1 | 2019 | 2435 | 0.08 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.08 | Why? |
| Lymphopenia | 1 | 2018 | 2669 | 0.08 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.08 | Why? |
| Adrenal Cortex Hormones | 2 | 2020 | 6537 | 0.07 | Why? |
| Risk Factors | 4 | 2019 | 71621 | 0.07 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.07 | Why? |
| Diet | 1 | 2018 | 2052 | 0.07 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.07 | Why? |
| Patient Isolation | 1 | 2018 | 3182 | 0.07 | Why? |
| Male | 11 | 2021 | 367725 | 0.07 | Why? |
| Texas | 1 | 2009 | 1237 | 0.07 | Why? |
| Infant | 2 | 2017 | 30274 | 0.07 | Why? |
| Female | 11 | 2021 | 380317 | 0.07 | Why? |
| Serologic Tests | 1 | 2018 | 4359 | 0.07 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.07 | Why? |
| Medical Oncology | 1 | 2020 | 3826 | 0.06 | Why? |
| Aged, 80 and over | 3 | 2018 | 88759 | 0.06 | Why? |
| Child, Preschool | 2 | 2017 | 36283 | 0.06 | Why? |
| Cause of Death | 1 | 2017 | 4823 | 0.06 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.06 | Why? |
| Ambulatory Care | 1 | 2018 | 4947 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.05 | Why? |
| Postoperative Complications | 1 | 2019 | 5861 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| Mortality | 1 | 2017 | 7132 | 0.05 | Why? |
| Transplantation, Autologous | 1 | 2021 | 364 | 0.05 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.04 | Why? |
| Child | 2 | 2017 | 70012 | 0.04 | Why? |
| Coinfection | 1 | 2017 | 6820 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Cell- and Tissue-Based Therapy | 1 | 2020 | 422 | 0.04 | Why? |
| Allografts | 1 | 2019 | 761 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Graft vs Host Disease | 1 | 2018 | 501 | 0.03 | Why? |
| Intersectoral Collaboration | 1 | 2020 | 1065 | 0.03 | Why? |
| Equipment Reuse | 1 | 2020 | 985 | 0.03 | Why? |
| Stem Cell Transplantation | 1 | 2018 | 531 | 0.03 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.03 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2019 | 25288 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2018 | 1083 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Patient Education as Topic | 1 | 2020 | 1476 | 0.03 | Why? |
| Hand Hygiene | 1 | 2020 | 1493 | 0.02 | Why? |
| Resource Allocation | 1 | 2020 | 1771 | 0.02 | Why? |
| Hospitalization | 1 | 2019 | 54280 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2021 | 6543 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Clinical Protocols | 1 | 2019 | 2734 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.02 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.02 | Why? |
| DNA, Viral | 1 | 2017 | 2521 | 0.02 | Why? |
| Protein Conformation | 1 | 2018 | 4386 | 0.02 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2020 | 3755 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| Societies, Medical | 1 | 2019 | 6907 | 0.02 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.01 | Why? |
| Algorithms | 1 | 2019 | 7346 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2009 | 27595 | 0.01 | Why? |
| Virus Shedding | 1 | 2018 | 5834 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Animals | 1 | 2020 | 78931 | 0.01 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.01 | Why? |